logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
I

Ian D. Davis

university of western australia

76H-index
690Paper Count
2.9WCitation Count
Published Papers 188
Publication Date
logo
Re: Transdermal Estradiol Patches in Locally Advanced Prostate Cancer
errEuropean Urology
IF25.2
err2026-06-17
err0
PREAI
errIan D. Davis
errShare
errSave
Predictive value of early PSMA upregulation for the response to enzalutamide ± 177Lu-PSMA-617 in poor-risk, metastatic, castration-resistant prostate cancer: substudy of the randomized, phase 2 ENZA-p trial
errNature Cancer
IF28.5
err2026-04-01
err0
PREAI
errEmmett, Louise; Swiha, Mina; Papa, Nathan; Subramaniam, Shalini; Crumbaker, Megan; Joshua, Anthony; Nguyen, Andrew; Weickhardt, Andrew; Lee, Sze-Ting; Ng, Siobhan; Francis, Roslyn; Goh, Jeffrey; Pattison, David; Pathmanandavel, Sarennya; Hope, Thomas; Ayati, Narjess; Hofman, Michael; Sandhu, Shahneen; Niu, Claire; Martin, Andrew; Thomas, Hayley; Stockler, Martin; Davis, Ian
errShare
errSave
Attrition Rates in Metastatic Renal Cell Carcinoma (mRCC) Following First Line Immunotherapy-Based Treatment: Results From the International mRCC Database Consortium (IMDC)
errClinical Genitourinary Cancer
IF2.7
err2026-01-01
err0
PREAI
errLemelin, Audreylie; Zarba, Martin; Takemura, Kosuke; Wells, J. Connor; Chehade, Razane El Hajj; Donskov, Frede; Porta, Camillo; De Velasco, Guillermo; Davis, Ian D.; Wood, Lori A.; Pal, Sumanta K.; Hansen, Aaron R.; Tran, Ben; Bjarnason, Georg A.; Li, Haoran; Kanesvaran, Ravindran; Powles, Thomas; Mckay, Rana R.; Choueiri, Toni K.; Heng, Daniel Y. C.
errShare
errSave
Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer
errNature Communications
IF15.7
err2025-12-17
err0
errOAAI
errSoumyajit Roy; Yilun Sun; Maha Hussain; Kim N. Chi; Karim Fizazi; Ian D. Davis; Susan Halabi; Neeraj Agarwal; Simon Chowdhury; Bertrand Tombal; Scott C. Morgan; Shawn Malone; Pedro C. Barata; Michael Ong; Christopher J. D. Wallis; Alejandro Berlin; Umang Swami; Amar U. Kishan; Angela Y. Jia; Nicholas G. Zaorsky; Jorge A. Garcia; Prateek Mendiratta; Jason R. Brown; Vinod V. Subhash; Martin R. Stockler; Hayley Thomas; Rana R. McKay; Eric J. Small; Neal D. Shore; Fred Saad; Christopher J. Sweeney; Daniel E. Spratt
errShare
errSave
A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024
errEuropean Journal of Cancer
IF7.1
err2025-11-21
err0
PREAI
errUrsula M. Vogl; Sara Merler; Antonio Angrisani; Fabio Turco; Ian D. Davis; Jason A. Efstathiou; Karim Fizazi; Nicholas D. James; Neal Shore; Eric J. Small; Matthew R. Smith; Christopher J. Sweeney; Bertrand Tombal; Thomas Zilli; Ken Herrmann; Aurelius Omlin; Silke Gillessen
errShare
errSave
Tumour-based epigenetic signatures as markers of prostate cancer aggressiveness after radical prostatectomy
errBritish Journal of Cancer
IF6.8
err2025-11-20
err0
PREAI
errYiyue Zhu; Elaheh Zarean; Danmeng L. Li; Robert L. O’Reilly; Ian D. Davis; Renea A. Taylor; Arun A. Azad; Damien M. Bolton; Nathan Papa; Nathan Lawrentschuk; Robert J. MacInnis; Roger L. Milne; Graham G. Giles; Melissa C. Southey; Pierre-Antoine Dugué
errShare
errSave
Target trial emulation of early docetaxel and enzalutamide for metastatic hormone-sensitive prostate cancer
errBJU International
IF4.4
err2025-11-05
err0
PREAI
errYu Yang Soon; Ian C. Marschner; I. Manjula Schou; Christopher J Sweeney; Ian D. Davis; Martin R. Stockler; Andrew J. Martin
errShare
errSave
Comparative Survival in Metastatic Hormone-sensitive Prostate Cancer by Volume of Disease and Timing of Metastasis: A Living Network Meta-analysis
errEuropean Urology
IF25.2
err2025-11-04
err0
PREAI
errIrbaz Bin Riaz; Syed Arsalan Ahmed Naqvi; Kunwer Sufyan Faisal; Huan He; Kaneez Zahra Rubab Khakwani; Daniel S. Childs; Jacob J. Orme; Praful Ravi; Parminder Singh; Syed A. Hussain; Kim Chi; Neeraj Agarwal; Axel S. Merseburger; Ian D. Davis; Andrew Armstrong; Maha H. Hussain; Matthew Smith; Gerhardt Attard; Bertrand Tombal; Karim Fizazi; Nick James; Aurelius Omlin; Silke Gillessen; Mohammad Hassan Murad; Eliezer M. Van Allen; Christopher J. Sweeney; Alan Haruo Bryce
errShare
errSave
What matters to society when making decisions about reimbursing drugs for prostate cancer: a discrete choice experiment
errJNCI: Journal of the National Cancer Institute
IF0
err2025-11-03
err0
errOAAI
errRafael Emilio De Feria Cardet, PhD; Stephen Goodall, PhD; Tracey-Lea Laba, PhD; Marion Haas, PhD; Ian D Davis, PhD; Deborah J Street, PhD; Christopher J Sweeney, PhD; Richard De Abreu Lourenço, PhD
errShare
errSave
Prognostic and predictive value of baseline PSMA-PET total tumour volume and SUVmean in metastatic castration-resistant prostate cancer in ENZA-p (ANZUP1901): a substudy from a multicentre, open-label, randomised, phase 2 trial
errlancet oncology
IF0
err2025-07-30
err0
PREAI
errLouise Emmett; Nathan Papa; Shalini Subramaniam; Megan Crumbaker; Andrew Nguyen; Anthony M Joshua; Shahneen Sandhu; Andrew Weickhardt; Sze-Ting Lee; Siobhan Ng; Roslyn J Francis; Jeffrey C Goh; David A Pattison; Thean Hsiang Tan; Ian D Kirkwood; Narjess Ayati; Claire Niu; Michael S Hofman; Andrew James Martin; Hayley Thomas; Ian D Davis; Martin R Stockler
errShare
errSave
How to Support Participants in Urogenital and Prostate Clinical Trials: A Qualitative Perspective
errPsycho-Oncology
IF3.5
err2025-07-14
err0
errOAAI
errNatasha A. Roberts; Ian D. Davis; David Wyld; Jeffrey Goh; Maxwell Thompson; Craig Gedye; Haryana M. Dhillon
errShare
errSave
If the Treatment for Metastatic Hormone-sensitive Prostate Cancer Stops Working, What Next?
errEuropean Urology
IF25.2
err2025-06-21
err0
PREAI
errIan D. Davis
errShare
errSave
Association of the circulating lipid panel, PCPro, with clinical outcomes in metastatic hormone-sensitive prostate cancer: post hoc analysis of the ENZAMET phase III randomised trial (ANZUP 1304)
errAnnals of Oncology
IF65.4
err2025-05-20
err0
PREAI
errH.-M. Lin; T. Scheinberg; N. Portman; R.M.N. Kim; R. Mellor; K. Huynh; A.N. Faulkner; N.A. Mellett; I.D. Davis; A. Martin; D. Sullivan; A. Joshua; M. McJannett; V. Subhash; S. Yip; A.A. Azad; I.C. Marschner; S.A. North; R.S. McDermott; K.N. Chi; M.R. Stockler; C.J. Sweeney; P.J. Meikle; L.G. Horvath
errShare
errSave
But Words Will Never Hurt Me
errEUROPEAN UROLOGY
IF25.2
err2025-03-01
err0
PREAI
errDavis, Ian D.; Anton, Angelyn; Kwan, Edmond M.
errShare
errSave
Validation of Prognostic and Predictive Models for Therapeutic Response in Patients Treated with [177Lu]Lu-PSMA-617 Versus Cabazitaxel for Metastatic Castration-resistant Prostate Cancer (TheraP): A Post Hoc Analysis from a Randomised, Open-label, Phase 2 Trial
errEUROPEAN UROLOGY ONCOLOGY
IF9.3
err2025-02-01
err3
errOAAI
errGafita, Andrei; Martin, Andrew J.; Emmett, Louise; Eiber, Matthias; Iravani, Amir; Fendler, Wolfgang P.; Buteau, James; Sandhu, Shahneen; Azad, Arun A.; Herrmann, Ken; Stockler, Martin R.; Davis, Ian D.; Hofman, Michael S.
errShare
errSave
Combination Therapies in Locally Advanced and Metastatic Hormone-sensitive Prostate Cancer
errEUROPEAN UROLOGY
IF25.2
err2025-02-01
err0
errOAAI
errAzad, Arun A.; Kostos, Louise; Agarwal, Neeraj; Attard, Gerhardt; Davis, Ian D.; Dorff, Tanya; Gillessen, Silke; Parker, Chris; Smith, Matthew R.; Sweeney, Christopher J.; Tombal, Bertrand; Fizazi, Karim
errShare
errSave
Enzalutamide in metastatic hormone-sensitive prostate cancer: A plain language summary of the ARCHES and ENZAMET follow-up studies
errFUTURE ONCOLOGY
IF2.6
err2024-10-15
err0
errOAAI
errArmstrong, Andrew J.; Azad, Arun A.; Conduit, Ciara; Haas, Gabriel P.; Bland, Christopher; Davis, Ian D.
errShare
errSave
Survival of men with metastatic hormone-sensitive prostate cancer and adrenal-permissive HSD3B1 inheritance
errJOURNAL OF CLINICAL INVESTIGATION
IF13.6
err2024-09-17
err1
errOAAI
errSharifi, Nima; Diaz, Robert; Lin, Hui-Ming; Roberts, Evan; Horvath, Lisa G.; Martin, Andrew; Stockler, Martin R.; Yip, Sonia; Subhash, Vinod V.; Portman, Neil; Davis, Ian D.; Sweeney, Christopher J.
errShare
errSave
Challenges of estimating treatment effects after a positive interim analysis
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2024-09-01
err0
PREAI
errSoon, Yu Yang; Marschner, Ian C.; Schou, Manjula; Sweeney, Christopher J.; Davis, Ian D.; Stockler, Martin R.; Martin, Andrew J.
errShare
errSave
Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502)
errEUROPEAN UROLOGY ONCOLOGY
IF9.3
err2024-06-01
err2
PREAI
errWeickhardt, Andrew; Foroudi, Farshad; Lawrentschuk, Nathan; Xie, Jing; Sidhom, Mark; Pal, Abhijit; Grimison, Peter; Zhang, Alison; Ng, Siobhan; Tang, Colin; Hovey, Elizabeth; Chen, Colin; Hruby, George; Guminski, Alexander; McJannett, Margaret; Conduit, Ciara; Tran, Ben; Davis, Ian D.; Hayne, Dickon
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
M
Mark A. Rubin
H-index: 186 · Papers: 1.5K
H
Howard I. Scher
H-index: 164 · Papers: 1.4K
G
Graham G. Giles
H-index: 164 · Papers: 2.4K
J
Johann S. de Bono
H-index: 160 · Papers: 2.5K
L
Lloyd J. Old
H-index: 155 · Papers: 961
View more